Successful Treatment of Pediatric Refractory Burkitt Lymphoma PTLD after Liver Transplantation using Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

In the immunocompromised setting, recipients of solid-organ or hematopoietic stem-cell transplants carry an increased risk of post-transplant lymphoproliferative disorder (PTLD). Burkitt lymphoma (BL) PTLD is a rare form of monomorphic B-cell PTLD, which lacks a standard best treatment. Here, we rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tianyi, Feng, Mingxuan, Luo, Chengjuan, Wan, Xinyu, Pan, Ci, Tang, Jingyan, Xue, Feng, Yin, Minzhi, Lu, Dongqing, Xia, Qiang, Li, Benshang, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917414/
https://www.ncbi.nlm.nih.gov/pubmed/33631963
http://dx.doi.org/10.1177/0963689721996649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917414/
https://www.ncbi.nlm.nih.gov/pubmed/33631963
http://dx.doi.org/10.1177/0963689721996649

Ejemplares similares